Genscript Biotech Corp
HKEX:1548

Watchlist Manager
Genscript Biotech Corp Logo
Genscript Biotech Corp
HKEX:1548
Watchlist
Price: 11 HKD 4.96% Market Closed
Market Cap: 23.1B HKD
Have any thoughts about
Genscript Biotech Corp?
Write Note

Gross Margin
Genscript Biotech Corp

53.6%
Current
53%
Average
43.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.6%
=
Gross Profit
541.5m
/
Revenue
1B

Gross Margin Across Competitors

Country CN
Market Cap 23.3B HKD
Gross Margin
54%
Country US
Market Cap 1.3T USD
Gross Margin
55%
Country US
Market Cap 201.7B USD
Gross Margin
41%
Country US
Market Cap 173.6B USD
Gross Margin
60%
Country KR
Market Cap 67.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.6B CHF
Gross Margin
29%
Country US
Market Cap 39.6B USD
Gross Margin
55%
Country US
Market Cap 36.8B USD
Gross Margin
35%
Country US
Market Cap 26.9B USD
Gross Margin
59%
Country US
Market Cap 23.5B USD
Gross Margin
35%
Country US
Market Cap 23.2B USD
Gross Margin
60%
No Stocks Found

Genscript Biotech Corp
Glance View

Market Cap
23.3B HKD
Industry
Life Sciences Tools & Services

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. The company is headquartered in Nanjing, Jiangsu. The company went IPO on 2015-12-30. The firm operates through four segments. Life Sciences Research Services segment includes gene and peptide synthesis, deoxyribonucleic acid (DNA) and primer synthesis, DNA sequencing, customized antibody production, protein expression and the production of stable cell lines. Preclinical Drug Development Services segment includes protein and antibody engineering, the study of in vitro drug and the study of in vivo drug. Life Sciences Research Catalog Products segment provides antibodies, recombinant proteins, equipment for protein isolation and analysis, molecular biology reagents, peptide, biochemicals and stable cell lines. Industrial Synthetic Biology Products segment is engaged in the development and production of industrial enzymes.

Intrinsic Value
32.97 HKD
Undervaluation 67%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
53.6%
=
Gross Profit
541.5m
/
Revenue
1B
What is the Gross Margin of Genscript Biotech Corp?

Based on Genscript Biotech Corp's most recent financial statements, the company has Gross Margin of 53.6%.